New Developments in Contraception

Dates this webinar will be offered:

This is an internet-based activity that should take 1 hour to complete.

To participate in this webinar learners should:

• Take the pre-test
• Listen to webinar
• Take the post-test
• Complete follow-up evaluation survey

Learning Objectives

At the conclusion of this activity, participants should be able to:

• Explain the need for new contraceptive methods in the US to improve reproductive health and prevent unintended pregnancy
• Examine the most recent contraceptive technologies to offer new options for patients in the United States
• Describe how new methods will meet patient needs to reduce unintended pregnancy in the US

Accreditation Information

Physicians:

Accreditation
The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation
ARHP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses:

This educational activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for 1.0 contact hour. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.

Pharmacists:

The Association of Reproductive Health Professionals (ARHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 1.0 contact hour of continuing education credit.

Others:

A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 Credit^TM.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project is funded through educational grants from Agile Therapeutics, Teva Pharmaceuticals, and Bayer HealthCare Pharmaceuticals.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Target Audience

The intended audiences for this activity are reproductive health professionals, including physicians, nurse midwives, nurse practitioners, physician assistants, pharmacists, students, educators, and researchers.

Advisory Committee Disclosures

ARHP Staff/Consultant Disclosures